Page 1

RNS Number : 5833Q Craneware plc 01 March 2021 Craneware plc ( " Craneware " , " the Group " or the " Company " ) Interim Results 1 March 2021 - Craneware ( AIM : CRW.L ) , the market leader in Value Cycle software solutions for the US healthcare market , announces its unaudited results for the six months ended 31 December 2020 . Financial Highlights ( US dollars ) 1 . . • • Revenue increased 6 % to $ 38m ( H1 2020 : $ 35.9m ) Adjusted EBITDA increased 5 % to $ 13.3m ( H1 2020 : $ 12.7m ) Profit before tax increased 3 % to $ 9.9m ( H1 2020 : $ 9.6m ) Adjusted basic EPS² increased 5 % to 32.5 cents per share ( H1 2020 : 31.1 cents per share ) Cash position of $ 50.7m ( H1 2020 : $ 45.0m ) Interim dividend increased 4 % to 12p per share ( H1 2020 : 11.5p per share ) Further investment in R & D and innovation of $ 11.6m ( H1 2020 : $ 10.3m ) , of which $ 4.5m capitalised ( H1 2020 : $ 4.0m ) , to take advantage of the growing market opportunity Adjusted EBITDA refers to earnings before interest , tax , depreciation , amortisation , share based payments and acquisition and share transaction related costs . 2. Adjusted Earnings per share ( EPS ) calculations allow for the tax adjusted acquisition costs and share related transactions together with amortisation on acquired intangible assets Operational Highlights Continued operational and financial progress despite ongoing COVID - 19 backdrop New Sales * more than 30 % ahead of strong comparable period in the prior year Strong growth in TrisusⓇ metrics : о More than 500 hospitals now using the Trisus platform Trisus solutions accounted for c . 16 % of New Sales ( H1 2020 : 10 % ) Over 90m anonymised aggregated patient encounters included within data on the platform , an increase of 30 % in the last three months Remaining core solutions , Chargemaster Toolkit and Pharmacy ChargeLink , on track to be migrated to the Trisus platform within the next twelve months Strong customer retention rates above 90 % with dollar value of renewals returned to c . 100 % Outlook